Infant Reflux
Clinical Snapshot
Infant regurgitation — the effortless return of swallowed milk into or out of the mouth, commonly called "spitting up" — is one of the most common concerns caregivers raise with a pharmacist in the first year of life, and in the large majority of cases it is a physiologic, self-limited process rather than a disease. Gastroesophageal reflux (GER) is simply the passage of stomach contents into the esophagus, with or without visible regurgitation or vomiting; gastroesophageal reflux disease (GERD) is the much less common situation where reflux causes troublesome symptoms affecting daily functioning or produces an actual complication — poor weight gain, significant feeding refusal or distress, respiratory symptoms, or esophagitis.[1] An infant who regurgitates frequently but feeds well, grows normally, and is generally content between episodes — the classic "happy spitter" — meets the formal diagnostic criteria for uncomplicated infant regurgitation, not GERD.[2]
Physiologic regurgitation is genuinely common: an estimated 20% of healthy infants regurgitate at least once daily by 1 month of age, rising to a peak of roughly 41% between 3 and 4 months, then declining steadily and becoming rare after 12 months of age as the lower esophageal sphincter matures, gastric capacity increases, and the infant spends progressively more time upright and eating a more solid diet.[1] This predictable, self-resolving course is the single most important fact to communicate to a worried caregiver — and the reason this chapter treats reassurance and feeding guidance as the primary, evidence-based "treatment" for most infants, reserving investigation and pharmacotherapy for the minority with true pathologic GERD.
Two genuinely different presentations
Physiologic regurgitation ("happy spitter")
Frequent, effortless spit-up in an infant who feeds well, is not in distress, and is growing along their expected curve. This is the presentation in most infants who regurgitate, and it needs reassurance and feeding guidance, not investigation or drug therapy.
Pathologic GERD
Regurgitation or reflux accompanied by poor weight gain, significant feeding refusal/distress, respiratory symptoms, or esophagitis — a much smaller minority of infants, who need a structured work-up and, once confirmed, active management rather than reassurance alone.
Cow's milk protein allergy (CMPA) overlap
CMPA can produce reflux-like regurgitation, feeding refusal, and distress that mimics or genuinely contributes to a GERD-type presentation — an important, often underrecognized differential and comorbidity rather than a separate rare condition (see Assessment & Diagnosis).
Recognize the Condition
Why infants reflux more than older children and adults
As in adults, the primary mechanism is a transient lower esophageal sphincter relaxation (TLESR) — a reflex sphincter opening unrelated to swallowing — but several features specific to infancy make this normal physiologic event far more likely to produce visible regurgitation: a shorter esophagus and smaller gastric capacity relative to feed volume, a more horizontal body position for much of the day, a liquid-predominant diet that crosses the gastroesophageal junction more easily than solid food, and a proportionally large volume of intake relative to body size.[3] Infants also have lower basal gastric acid output than older children and adults, and frequent milk feeds provide an ongoing buffering effect, so even when reflux does occur the refluxate itself is typically less acidic — one reason acid-suppressing therapy is a poor fit for most infant regurgitation even before efficacy and safety data are considered (see Choose Initial Treatment).[4]
Typical presentation of physiologic regurgitation
Regurgitation is effortless — not forceful or projectile — occurs mainly after feeds, and is not accompanied by crying, arching, feeding refusal, or blood. It is not usually present in the first week of life and does not typically begin new after about 6 months of age; either pattern is atypical and worth a closer look rather than an automatic reflux label.[3] Between and during episodes the infant feeds well, sleeps reasonably, and — most importantly — continues to gain weight along their expected growth curve. Formal Rome IV diagnostic criteria for uncomplicated infant regurgitation require an otherwise healthy infant 3 weeks to 12 months of age with regurgitation two or more times per day for three or more weeks, and none of retching, hematemesis, aspiration, apnea, failure to thrive, feeding or swallowing difficulty, or abnormal posturing.[2]
Features suggesting pathologic GERD rather than physiologic regurgitation
Persistent or worsening feeding refusal; irritability or unusual neck/trunk arching that specifically clusters around feeds (sometimes called Sandifer syndrome when posturing is prominent); poor weight gain or frank failure to thrive; recurrent respiratory symptoms (cough, wheeze, or apparent aspiration episodes); or hematemesis point toward pathologic GERD or another diagnosis entirely rather than simple physiologic regurgitation (see Red Flags & Refer and Assessment & Diagnosis).
Risk Factors
Physiologic regurgitation is, in effect, the common extreme of a universal infant developmental process rather than a disease with its own risk factors — nearly every infant experiences transient lower esophageal sphincter relaxations, and most experience at least some visible regurgitation as a result.[3] A smaller group of infants and situations carry a materially higher chance that reflux will become pathologic GERD, or that a different diagnosis is actually driving the symptoms:
- Prematurity — preterm infants have further immaturity of esophageal motility and lower esophageal sphincter tone, and genuinely higher rates of pathologic GERD than term infants (see Special Populations).[3]
- Neurologic impairment — conditions affecting muscle tone, motility, or the ability to reliably communicate distress (e.g., cerebral palsy, significant global developmental delay) are associated with materially higher rates of pathologic GERD and its complications (see Special Populations).[3]
- Overfeeding, or feeding volumes/frequency inappropriate for age — a common, easily corrected contributor to visible regurgitation that is not itself GERD (see Non-Pharmacologic Treatment).
- A family history of GERD, or a personal/family history of atopy — the latter raises the specific likelihood that cow's milk protein allergy, rather than idiopathic reflux, is contributing to or mimicking the presentation (see Assessment & Diagnosis).
- Hiatal hernia, or a structural gastrointestinal anomaly (e.g., a history of repaired esophageal atresia/tracheoesophageal fistula, or a diaphragmatic hernia) — uncommon, but a reason to keep a broader differential in mind for regurgitation or vomiting that does not fit the typical benign pattern.
- Feeding type — there is no consistent evidence that breastfeeding versus formula feeding changes how much an infant physiologically refluxes; both groups commonly regurgitate.
Red Flags & Refer
Any of the following means this is not simple physiologic regurgitation, and warrants prompt medical assessment rather than reassurance alone:
- Poor weight gain, weight loss, or failure to thrive — a physiologically regurgitating infant gains weight normally; growth faltering points to pathologic GERD, cow's milk protein allergy, inadequate intake, or another underlying illness.[1]
- Forceful or projectile vomiting, especially if new in the first weeks of life — this pattern is not typical physiologic reflux and should specifically raise concern for pyloric stenosis, which classically presents with worsening, non-bile-stained projectile vomiting between about 2 and 8 weeks of age and needs urgent assessment, not reflux counselling.[3]
- Bilious (green or yellow-green) vomiting — raises concern for a bowel obstruction or malrotation with volvulus; treat as a surgical emergency until excluded.
- Bloody vomiting or blood in the stool — suggests esophagitis, cow's milk protein allergy/proctocolitis, an anal fissure, or another gastrointestinal process depending on the pattern; needs assessment rather than a reflux label.
- Respiratory symptoms or apparent aspiration — recurrent cough, wheeze, choking with feeds, or an apparent life-threatening event in association with reflux.
- Feeding refusal with significant, persistent distress — occasional fussiness around a feed is common; an infant who consistently arches, cries, and resists feeding is showing a pattern beyond simple physiologic regurgitation.
- Lethargy, fever, or a bulging fontanelle — evaluate urgently for a non-GI cause (infection, raised intracranial pressure) rather than attributing symptoms to reflux.
- Onset before 2 weeks of age, new onset after about 6 months of age, or symptoms that persist essentially unchanged well beyond 12-18 months — each falls outside the typical pattern and timeline of physiologic regurgitation and warrants reassessment.[3]
Assessment & Diagnosis
Diagnosis is clinical
For an infant with the typical pattern — effortless, postprandial regurgitation in a well, thriving infant — the diagnosis of physiologic regurgitation is made on history and a normal growth trajectory, and does not require laboratory testing or imaging.[1] This is a genuinely important counselling and prescribing-restraint point: pH-probe monitoring and endoscopic findings correlate only weakly with reported infant symptoms such as crying, fussing, or arching, so these investigations are not indicated simply to confirm or explain typical regurgitation, and pursuing them in a well-growing infant adds cost, discomfort, and parental anxiety without a corresponding benefit.[1]
Rome IV criteria for uncomplicated infant regurgitation
A useful, concrete clinical framework: an otherwise healthy infant 3 weeks to 12 months of age with (1) regurgitation two or more times per day for three or more weeks, and (2) none of retching, hematemesis, aspiration, apnea, failure to thrive, feeding or swallowing difficulty, or abnormal posturing.[2]
Differential diagnosis to keep in mind
| Condition | Distinguishing clue | Why it matters |
|---|---|---|
| Cow's milk protein allergy (CMPA) | Blood/mucus in stool, eczema, significant feeding refusal or distress, family atopy history, symptoms alongside — not only during — feeds | A genuinely common overlap/mimic; may respond to a hydrolyzed formula or maternal elimination trial rather than acid suppression (see Non-Pharmacologic Treatment). |
| Pyloric stenosis | New, worsening, forceful/projectile, non-bile vomiting, typically presenting between 2 and 8 weeks of age; may develop a palpable "olive" mass and hungry-after-vomiting behaviour | A time-sensitive surgical diagnosis, not managed as reflux. |
| Overfeeding | Feed volumes or frequency exceeding age-appropriate norms; regurgitation improves promptly once feeding volume/frequency is adjusted | An easily corrected contributor that does not need a GERD label or work-up. |
| Anatomic anomaly (malrotation with volvulus, intestinal obstruction, esophageal/duodenal anomaly) | Bilious vomiting, abdominal distension, bloody stool, an unwell-appearing infant | Surgical emergencies requiring urgent evaluation, not reflux counselling. |
| Infection (urinary tract infection, gastroenteritis, sepsis) | Fever, lethargy, poor feeding, diarrhea | Vomiting from infection needs its own evaluation regardless of a coexisting reflux pattern. |
| Inborn error of metabolism | Recurrent vomiting with lethargy, poor growth, or an abnormal neurologic exam, especially with a concerning family history | Uncommon but important not to miss in an infant who is not simply a well, thriving "happy spitter." |
When investigation or referral is appropriate
Reserve testing and pediatric gastroenterology referral for infants with an actual red flag (see Red Flags & Refer), growth faltering, or symptoms persisting despite an adequate trial of the non-pharmacologic measures below — not for typical, well-growing "happy spitters."[1] When pathologic GERD is genuinely suspected, ambulatory pH/impedance monitoring and, in some cases, upper endoscopy are used by pediatric specialists to confirm abnormal esophageal acid exposure or esophagitis and to guide treatment — these are specialist-directed investigations, not a routine primary-care or pharmacist-initiated work-up.
Treatment Targets
- For physiologic regurgitation (the large majority of infants): provide accurate reassurance and practical feeding guidance — genuinely the correct, evidence-based "treatment," not a placeholder while waiting for a prescription.
- Avoid harm from unnecessary investigation or unproven/unsafe pharmacotherapy in an infant who does not need it.
- For confirmed pathologic GERD: control symptoms, support adequate growth, promote healing of any esophagitis present, and reduce the risk of respiratory or feeding-related complications.
- Identify and address a cow's milk protein allergy overlap when specific clues are present, rather than treating it as reflux alone.
- Recognize the minority of infants (red flags, prematurity, neurologic impairment) who need a lower threshold for referral rather than applying the standard reassurance-first approach uniformly.
Choose Initial Treatment
Foundation of management — every infant
1st line, every infant with physiologic regurgitation confirm no red flag is present and growth is normal (see Assessment & Diagnosis), then provide direct reassurance and feeding-technique guidance: explain that this is common, benign, and reliably improves as the lower esophageal sphincter matures and the infant spends more time upright and eating solid food, typically resolved by 12-18 months of age.[1] Pair this with the specific feeding modifications in Non-Pharmacologic Treatment.
A modest, selective role for feeding-based interventions
Consider — significant, distressing visible regurgitation despite feeding modifications a 2-week trial of thickened feeds (a commercial infant-safe thickener, or a formulated anti-regurgitation formula for formula-fed infants); trial evidence shows this reduces the number of visible regurgitation/vomiting episodes and improved weight gain in some trials, even though it does not change underlying esophageal acid exposure on pH testing.[1]
Consider — a specific cow's milk protein allergy clue present (see Assessment & Diagnosis) a 2-4 week trial of an extensively hydrolyzed or amino-acid formula (formula-fed), or maternal dairy and other suspected-allergen elimination while continuing to breastfeed; reassess objectively at the end of the trial and stop if there is no clear improvement rather than continuing indefinitely or cycling through further formula changes.[1]
Pharmacologic management has a genuinely limited role
Do not use acid suppression (a PPI or an H2RA) for uncomplicated regurgitation or a "happy spitter" presentation, including for crying, fussiness, arching, or visible spit-up without other red-flag features. A placebo-controlled trial of over 150 infants found no benefit of lansoprazole over placebo for crying/fussing, while adverse events were more frequent with active drug; acid suppression also has real safety associations in infants, including increased respiratory and gastrointestinal infections, increased necrotizing enterocolitis, infection, and mortality with H2RA use specifically in very-low-birth-weight infants, and an association between early, prolonged acid-suppressant use and increased fracture risk later in childhood.[1]
Do not use metoclopramide — evidence does not support efficacy for pediatric GERD, and it carries real extrapyramidal/tardive dyskinesia risk in this population; Health Canada has advised against its use in infants under 1 year of age since 2015.[1]
Do not use domperidone — no robust evidence of benefit for pediatric GERD, and Health Canada issued specific safety warnings in 2012 and 2015 about an increased risk of serious cardiac events and sudden death associated with its use.[1]
Reserve acid suppression for confirmed pathologic GERD — esophagitis, or growth/feeding failure attributable to reflux — under pediatric gastroenterology or specialist guidance, at the lowest effective dose for the shortest duration needed (typically an initial 4-8 week course), with a defined reassessment plan rather than open-ended continuation.[1]
Non-Pharmacologic Treatment
Feeding modifications
- Smaller, more frequent feeds — reduces gastric distension and the volume available to reflux, without reducing total daily intake.
- Careful attention to burping technique — burp the infant during and after feeds to reduce swallowed air, which can otherwise distend the stomach and provoke transient lower esophageal sphincter relaxations.
- Avoid overfeeding — confirm feed volumes and frequency are appropriate for the infant's age and weight rather than assuming more volume will settle a fussy infant.
- Upright positioning after feeds — holding the infant upright for roughly 20-30 minutes after a feed, while awake and directly supervised, can reduce visible regurgitation.
Positioning — a critical safe-sleep distinction
Awake, supervised upright or side positioning after a feed is reasonable for reflux comfort, but this is entirely separate from sleep position. Always place the infant supine (on the back) for every sleep, on a flat surface with no loose bedding, exactly as for any other infant — this is the strongly evidence-based position for reducing the risk of sudden infant death syndrome, and it should never be overridden by a wish to reduce reflux. Do not recommend prone or side sleeping, an elevated crib mattress, or any other sleep-positioning device for reflux — the SIDS-prevention evidence for supine sleep is far stronger than any reflux-specific benefit of an alternate sleep position, and current guidance is explicit that positional therapy for reflux should be discouraged for this reason.[1]
Thickened feeds
A 2-week trial of thickened feeds — a commercial infant-safe thickener added to expressed breast milk or formula, or a switch to a formulated anti-regurgitation ("AR") formula for formula-fed infants — can be attempted for infants with significant, visible vomiting/regurgitation once simple feeding modifications alone are not enough. Evidence from multiple randomized trials shows thickened feeds reduce the number of daily vomiting/regurgitation episodes and improved weight gain in some trials, even though they do not change esophageal acid exposure on pH monitoring — they help with the visible mess and, in some infants, with growth, without necessarily treating an underlying acid-reflux process.[1] A pharmacist or dietitian can help confirm an infant-appropriate thickener and consistency; do not thicken feeds with cereal or another non-formulated approach without guidance, particularly in young infants.
Cow's milk protein allergy trial, when specifically suspected
When a specific clue points to cow's milk protein allergy rather than, or in addition to, simple reflux — blood or mucus in the stool, eczema, a strong family atopy history, or significant feeding refusal/distress alongside the regurgitation (see Assessment & Diagnosis) — a 2-4 week trial is reasonable: for a formula-fed infant, a switch to an extensively hydrolyzed formula, or an amino-acid formula if there is no response to a hydrolyzed formula; for a breastfed infant, maternal elimination of dairy and other common allergens as indicated, while continuing to breastfeed.[1] Reassess objectively at the end of the trial and stop — resuming the usual diet/formula — if there is no clear improvement, rather than continuing indefinitely or repeating further empiric formula changes.
Patient education — the primary intervention for most infants
For the large majority of infants with physiologic regurgitation, accurate education and reassurance genuinely is the correct, evidence-based management, not a placeholder before a prescription. Explain plainly: this is extremely common, it does not mean something is medically wrong or that the caregiver is doing something wrong, it is not typically painful reflux disease, and it reliably improves over the first year as the lower esophageal sphincter matures, gastric capacity increases, and the infant spends more time upright and eating solid food, with the great majority resolved by 12-18 months of age.[1] Proactively correct common misconceptions: that repeated formula switching without a specific CMPA clue will fix ordinary spit-up, that visible regurgitation volume reflects how "bad" the reflux is or correlates with discomfort, or that acid-suppressing medication is an appropriate or effective first step. Give a clear, concrete plan for what should prompt a return visit (see Red Flags & Refer and Treatment Failure/Next Step) so reassurance is paired with genuine safety-netting, not a dismissal.
Special Populations
Premature infants
Preterm infants have further immaturity of esophageal motility, lower esophageal sphincter tone, and gastric emptying, and genuinely higher rates of pathologic GERD than term infants.[3] Apply a lower threshold for specialist involvement and closer growth/respiratory monitoring in this group rather than assuming the standard reassurance-first approach used for term "happy spitters" applies equally.
Infants with neurologic impairment
Conditions affecting muscle tone, esophageal motility, or the ability to reliably communicate distress (e.g., cerebral palsy, significant global developmental delay) are associated with materially higher rates of pathologic GERD, esophagitis, and aspiration.[3] These infants may not present with typical crying or arching, so maintain a lower threshold for specialist referral when regurgitation is prominent, growth is uncertain, or respiratory symptoms are present.
Breastfed infants
There is no consistent evidence that breastfeeding itself causes more, or less, regurgitation than formula feeding — support continued breastfeeding rather than allowing a mistaken belief that breast milk is "the problem" to end it prematurely. If a cow's milk protein allergy clue is present, a maternal dietary elimination trial is the appropriate step, not stopping breastfeeding.
Formula-fed infants
Confirm feed preparation, volume, and frequency are age-appropriate before attributing regurgitation to the formula itself. If a cow's milk protein allergy clue is present, an extensively hydrolyzed or amino-acid formula trial is appropriate (see Non-Pharmacologic Treatment) — repeated switching between standard formulas without a specific clue is not evidence-based and adds cost without benefit.
Infants with a structural or surgical history
A history of repaired esophageal atresia/tracheoesophageal fistula, congenital diaphragmatic hernia, or another structural gastrointestinal anomaly carries a higher baseline rate of true GERD and its complications. These infants are typically already under specialist follow-up, and any new or worsening reflux symptom should be discussed with that team rather than managed as ordinary physiologic regurgitation.
Monitoring & Follow-Up
For physiologic regurgitation, the growth trajectory is the single most useful ongoing reassurance point — confirm it remains normal at each well-child or pharmacy contact rather than focusing on the volume or frequency of visible spit-up, which does not reliably track with anything clinically important.
- Reassess for any new red flag at each contact (see Red Flags & Refer), since an infant's presentation can evolve over the first year.
- If a thickened-feed/anti-regurgitation-formula trial or a cow's milk protein allergy trial was started, confirm at the planned 2-week (thickened feeds) or 2-4-week (CMPA trial) mark whether it is helping, and stop it if not, rather than continuing indefinitely.[1]
- Reinforce feeding technique and safe supine sleep positioning at follow-up, not only at the initial conversation.
- For an infant on specialist-directed acid suppression for confirmed pathologic GERD, confirm the planned reassessment date (typically 4-8 weeks) is being kept, and do not allow the prescription to continue open-endedly without that reassessment.[1]
- Track the outcome that matters most: steady growth and a content, well-feeding infant, not complete elimination of visible spit-up, which may not happen until well into the second half of the first year regardless of intervention.
Common Errors to Avoid
- Prescribing or recommending a PPI or H2RA for an infant with typical, well-growing "happy spitter" regurgitation, crying, or fussiness — trial evidence does not show benefit over placebo for these presentations, and acid suppression carries real infection, and, with early or prolonged use, fracture-risk associations in infants.[1]
- Recommending or dispensing metoclopramide for infant GERD — Health Canada has specifically advised against use in infants under 1 year of age since 2015, and evidence does not support efficacy in this population.[1]
- Recommending or dispensing domperidone for infant GERD — Health Canada issued specific cardiac-safety warnings in 2012 and 2015, with no offsetting evidence of benefit for this indication.[1]
- Recommending prone or side sleep positioning, an elevated mattress, or another sleep-positioning product to reduce reflux — this overrides the far stronger SIDS-prevention evidence for supine sleep and should never be suggested.[1]
- Encouraging repeated formula switching without a specific cow's milk protein allergy clue present — this adds cost and disrupts feeding without evidence of benefit.
- Ordering or requesting pH-probe monitoring or endoscopy for a well, thriving infant with typical regurgitation — these tests correlate only weakly with symptoms and are not indicated for routine confirmation.[1]
- Labelling new, forceful/projectile vomiting — especially in the first weeks of life — as "just reflux" without considering pyloric stenosis, which needs urgent surgical assessment, not reflux counselling.
- Applying the standard reassurance-first approach uniformly to a premature or neurologically impaired infant without recognizing their genuinely higher rate of pathologic GERD and lower threshold for specialist referral.
- Treating reassurance as a one-time conversation rather than reinforcing it, and re-screening for red flags, at every follow-up contact through the first year.
Clinical Decision Algorithm
Drug Tables
How to use this table: pharmacotherapy has a genuinely limited role in infant reflux — feeding-based measures and caregiver education (see Non-Pharmacologic Treatment) remain first-line for the large majority of infants. Doses shown for acid suppression are pediatric weight-based doses and require patient-specific confirmation. Select any linked drug name to open its complete Pharmasist Drug Database page.
Feeding-based interventions with genuine, though modest, evidence
Try before, or alongside, any consideration of pharmacotherapy — these have a materially better risk-benefit profile than acid suppression for the presentations most infants actually have.
| Drug/intervention | Dosage | Adverse effects | Drug interactions | Comments |
|---|---|---|---|---|
| Thickened feeds / anti-regurgitation (AR) formula | Trial: A commercial infant-safe thickener added to expressed breast milk or formula, or a switch to a formulated AR formula, for a 2-week trial | Generally well tolerated; confirm an infant-appropriate thickener and consistency with a pharmacist or dietitian | None significant | Reduces visible regurgitation/vomiting episodes and improved weight gain in some trials; does not change esophageal acid exposure on pH testing. |
| Extensively hydrolyzed or amino-acid formula (formula-fed), or maternal dairy elimination (breastfed) | Formula-fed trial: Extensively hydrolyzed formula for 2-4 weeks, then reassess; try an amino-acid formula if no response to a hydrolyzed formula Breastfed trial: Maternal elimination of dairy and other common allergens as indicated, for 2-4 weeks while continuing to breastfeed, then reassess | Hydrolyzed/amino-acid formula: bitter taste may reduce acceptance, higher cost. Maternal elimination: risk of inadequate calcium/vitamin D intake if prolonged without dietary guidance | None significant | Reserve for a specific cow's milk protein allergy clue (blood/mucus in stool, eczema, strong atopy history) rather than trialing in every regurgitating infant; reassess and stop if no clear benefit. |
Acid suppression — reserved for confirmed pathologic GERD, under specialist guidance
Not indicated for uncomplicated regurgitation, crying, or fussiness (see Choose Initial Treatment). Doses shown are pediatric weight-based doses used once a specialist has confirmed a pathologic-GERD indication; always confirm against the current product monograph and the infant's actual weight.
| Drug/intervention | Dosage | Adverse effects | Drug interactions | Comments |
|---|---|---|---|---|
| Omeprazole | 3-5 kg: 2.5 mg PO once daily 5-10 kg: 5 mg PO once daily 10-20 kg: 10 mg PO once daily | Headache, diarrhea, constipation, abdominal pain | May reduce absorption of drugs requiring gastric acidity (e.g., certain antifungals, iron salts) | No demonstrated benefit over placebo for crying/fussing or uncomplicated regurgitation — reserve for confirmed pathologic GERD. |
| Esomeprazole | 3-5 kg: 2 mg PO once daily 5-7.5 kg: 5 mg PO once daily 7.5-20 kg: 10 mg PO once daily | Headache, diarrhea, abdominal pain, rash | Inhibits CYP2C19 — may increase levels of drugs cleared through this pathway | Same reserved role and evidence limitations as omeprazole. |
| Famotidine | Under 3 months: 0.5 mg/kg/dose PO once daily 3 months and older: 0.5 mg/kg/dose PO twice daily, maximum 40 mg/day | Headache, constipation, diarrhea, irritability | Minimal significant drug-interaction profile | Faster onset than a PPI but not reliably effective for healing esophagitis; regular continuous use leads to rapid tachyphylaxis. |
Agents to avoid
Included because these are sometimes still requested or prescribed for infant reflux or crying despite an unfavourable evidence and safety profile in this age group.
| Drug/intervention | Dosage | Adverse effects | Drug interactions | Comments |
|---|---|---|---|---|
| Metoclopramide | Infant GERD use: Not recommended in infants under 1 year of age | Extrapyramidal symptoms and tardive dyskinesia (risk increases with cumulative dose/duration), diarrhea, sedation, irritability | Additive sedation with other CNS depressants; additive extrapyramidal risk with other dopamine antagonists | Evidence does not support efficacy for pediatric GERD; Health Canada has advised against use in infants under 1 year of age since 2015. |
| Domperidone | Infant GERD use: Not recommended | QT-interval prolongation; rare serious ventricular arrhythmia and sudden cardiac death | CYP3A4 inhibitors (e.g., certain azole antifungals, macrolides) further increase QT-prolongation risk | No robust evidence of benefit for pediatric GERD; Health Canada issued specific safety warnings in 2012 and 2015. |
References
- Medical management of gastro-esophageal reflux in healthy infants — Canadian Paediatric Society (Chevalier I, Beck CE, Dore-Bergeron MJ, Orkin J). Canadian Paediatric Society practice point, published November 4, 2022
- Childhood Functional Gastrointestinal Disorders: Neonate/Toddler — Gastroenterology (Benninga MA, Nurko S, Faure C, Hyman PE, St James Roberts I, Schechter NL). Gastroenterology 2016;150(6):1443-1455
- Pediatric Gastroesophageal Reflux Clinical Practice Guidelines: Joint Recommendations of NASPGHAN and ESPGHAN — Journal of Pediatric Gastroenterology and Nutrition (Rosen R, Vandenplas Y, Singendonk M, et al.). J Pediatr Gastroenterol Nutr 2018;66(3):516-554
- Reducing the use of proton pump inhibitors in infants with gastroesophageal reflux symptoms — Canadian Family Physician (Størdal K, Beck CE). Can Fam Physician 2025;71(3):170-172
Professional reference only. Apply clinical judgment and verify patient-specific decisions against current authoritative guidance and product information.